Trials / Unknown
UnknownNCT04026932
The Clinical Effects of Modified TRS Treatment
The Clinical Effects of Modified Tinnitus Relieving Sound Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Eye & ENT Hospital of Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Objective Tinnitus is one of the most common acoustic disorders by affecting 5-43% people around the world, and tinnitus is harmful to social and individuals, inducing to annoyance, irritability, anxiety, depression, insomnia and concentration difficulties. Many efforts have been made to help tinnitus suffers, however, the curative means are still in absence. This study aims to introduce a novel sound therapy for tinnitus and to evaluate the efficacy of modified tinnitus relieving sound treatment in comparison with unmodified music which served as a control. Methods and analysis A randomized, triple-blinded, controlled, clinical trial will be carried out. 68 patients with subjective tinnitus will be recruited and randomized into two groups in 1:1 ratio. The primary outcomes will be Tinnitus Handicapped Inventory (THI), Hospital Anxiety and Distress Scale (HADS), and visual analogue scale (VAS) for tinnitus; the secondary outcome measures will be Athens Insomnia Scale (AIS), tinnitus loudness matched by sensation level (LM, SL), and minimum masking level (MML). Assessment will be performed at baseline and at 1, 3, 9, and 12 months post-randomization. The sound stimulus will be persistent until 9 months after randomization, and be interdictory in the last three months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Listening to unmodified music | Listening to unmodified music for at least 2 hours a day |
| OTHER | Listening to modified tinnitus relieving sound | Listening to modified tinnitus relieving sound for at least 2 hours a day |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2021-08-01
- Completion
- 2022-02-01
- First posted
- 2019-07-19
- Last updated
- 2019-07-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04026932. Inclusion in this directory is not an endorsement.